Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	PTPc_motif	PTPN4 TNS1	6.09e-03	59	37	2	SM00404
Domain	Tyr_Pase_cat	PTPN4 TNS1	6.09e-03	59	37	2	IPR003595
Pubmed	Heterotaxy-spectrum heart defects in Zic3 hypomorphic mice.	ZIC3 TBX5	1.16e-05	5	38	2	23999067
Pubmed	Specific mesenchymal/epithelial induction of olfactory receptor, vomeronasal, and gonadotropin-releasing hormone (GnRH) neurons.	LHX2 TBX5	1.76e-04	18	38	2	20503368
Pubmed	Neuroretina specification in mouse embryos requires Six3-mediated suppression of Wnt8b in the anterior neural plate.	LHX2 TBX5	1.96e-04	19	38	2	20890044
Pubmed	The transcription factor Maz is essential for normal eye development.	LHX2 TBX5	2.41e-04	21	38	2	32571845
Pubmed	Optic vesicle morphogenesis requires primary cilia.	LHX2 TBX5	2.41e-04	21	38	2	32169553
Pubmed	T-box3 is a ciliary protein and regulates stability of the Gli3 transcription factor to control digit number.	ZIC3 TBX5	3.43e-04	25	38	2	27046536
Pubmed	Canonical Wnt/β-catenin signalling is essential for optic cup formation.	LHX2 TBX5	4.63e-04	29	38	2	24324671
Pubmed	Lhx2 links the intrinsic and extrinsic factors that control optic cup formation.	LHX2 TBX5	4.63e-04	29	38	2	19906857
Pubmed	Multiple loci are associated with white blood cell phenotypes.	MED24 CERKL	6.01e-04	33	38	2	21738480
Pubmed	Tbx1 is required autonomously for cell survival and fate in the pharyngeal core mesoderm to form the muscles of mastication.	LHX2 TBX5	6.01e-04	33	38	2	24705356
Pubmed	The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency.	ALPL ZIC3	6.38e-04	34	38	2	20007774
GeneFamily	Olfactory receptors, family 52	OR52N1 OR52E8	1.91e-03	49	24	2	165
GeneFamily	Sterile alpha motif domain containing	SAMD9L EPHA1	6.03e-03	88	24	2	760
GeneFamily	SH2 domain containing	TNS1 SH3BP2	7.87e-03	101	24	2	741
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	CASP2 TNS1	2.38e-02	181	24	2	694
CoexpressionAtlas	kidney_adult_GlomCapSys_Tie2_k-means-cluster#1_top-relative-expression-ranked_500	SAMD9L TNS1 ALPL	1.95e-05	31	36	3	gudmap_kidney_adult_GlomCapSys_Tie2_k1_500
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PEPD EHHADH SH3BP2 AOX1	1.87e-05	186	38	4	b1edc341d6684b347dc9e21b34f62f51d095d735
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PEPD EHHADH SH3BP2 AOX1	1.91e-05	187	38	4	f1356273bd3587b6883295edf15cb9cdb706c057
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PEPD EHHADH SH3BP2 AOX1	1.91e-05	187	38	4	dcf6475ece5b34d9d58a0d1f51c18acedb19c119
Drug	Protoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A	CEP104 LHX2 DMXL2 TMEM62 EPHA1	1.50e-05	189	38	5	2800_DN
Drug	thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	CASP2 MED24 LHX2 TNS1 EHHADH	1.58e-05	191	38	5	4454_DN
Drug	thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	CASP2 CEP104 MED24 LHX2 EPHA1	1.66e-05	193	38	5	1230_DN
Drug	Gramine [87-52-5]; Up 200; 23uM; MCF7; HT_HG-U133A	TNS1 SH3BP2 ZIC3 AOX1 TBX5	1.66e-05	193	38	5	4118_UP
Drug	Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A	MED24 LHX2 BTD ZNF446 SH3BP2	1.79e-05	196	38	5	4793_DN
Drug	Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; MCF7; HT_HG-U133A	CASP2 EHHADH BTD SH3BP2 EPHA1	1.83e-05	197	38	5	3549_DN
Drug	Diazoxide [364-98-7]; Up 200; 17.4uM; MCF7; HT_HG-U133A	CEP104 TNS1 BTD SH3BP2 TBX5	1.88e-05	198	38	5	2214_UP
Drug	cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Down 200; 100uM; MCF7; HT_HG-U133A_EA	CASP2 CEP104 LHX2 BTD AOX1	1.88e-05	198	38	5	881_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	CEP104 ABHD14A TMEM62 BTD AOX1	1.93e-05	199	38	5	6941_UP
Drug	vanillic acid	CCDC6 EHHADH AOX1	2.06e-05	32	38	3	CID000008468
Drug	Nivalenol hydrate	A1BG HRC EPHA1	3.48e-05	38	38	3	CID000031829
Drug	p-dimethylaminocinnamaldehyde	ALPL AOX1	5.67e-05	7	38	2	CID000092224
Drug	triphenylamine	CCDC6 BTD	7.55e-05	8	38	2	CID000011775
Drug	lead nitrate	LHX2 EHHADH ALPL	8.96e-05	52	38	3	CID000024924
Drug	Ao G	PTPN4 AOX1	1.21e-04	10	38	2	CID000448297
Drug	[(E)-[amino-[ethyl(nitroso)amino]methylidene]amino]-hydroxy-oxoazanium	PEPD PTPN4	1.48e-04	11	38	2	CID009572846
Drug	AC1L1UJE	LHX2 PYROXD2	2.09e-04	13	38	2	CID000010121
Drug	phosphinate	A1BG EPHA1 ZIC3	2.17e-04	70	38	3	CID000022497
Drug	isoxanthopterin	CCDC6 AOX1	2.44e-04	14	38	2	CID000010729
Drug	Withaferin A [5119-48-2]; Down 200; 1uM; PC3; HT_HG-U133A	CASP2 TNS1 EPHA1 TBX5	2.56e-04	186	38	4	3819_DN
Drug	5224221; Down 200; 12uM; MCF7; HT_HG-U133A_EA	ABHD14A LHX2 EHHADH AOX1	2.56e-04	186	38	4	839_DN
Drug	Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A	CASP2 TNS1 ZNF446 TBX5	2.83e-04	191	38	4	3815_DN
Drug	rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA	CASP2 LHX2 MLXIP BTD	2.83e-04	191	38	4	941_DN
Drug	Proguanil hydrochloride [637-32-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ABHD14A BTD SH3BP2 EPHA1	2.89e-04	192	38	4	3505_DN
Drug	Enilconazole [35554-44-0]; Down 200; 13.4uM; HL60; HT_HG-U133A	CEP104 ABHD14A TNS1 SH3BP2	2.95e-04	193	38	4	3139_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A	LHX2 MLXIP EPHA1 AOX1	2.95e-04	193	38	4	1644_DN
Drug	pararosaniline base; Down 200; 10uM; MCF7; HT_HG-U133A_EA	CASP2 LHX2 BTD EPHA1	2.95e-04	193	38	4	893_DN
Drug	Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A	ABHD14A BICRAL BTD SH3BP2	2.95e-04	193	38	4	7232_DN
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; MCF7; HT_HG-U133A	CASP2 LHX2 SH3BP2 TBX5	3.01e-04	194	38	4	3910_DN
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A	CASP2 TNS1 BTD EPHA1	3.01e-04	194	38	4	4738_DN
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	LHX2 DMXL2 TNS1 EPHA1	3.01e-04	194	38	4	4763_DN
Drug	Etifenin [63245-28-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A	LHX2 SH3BP2 EPHA1 TBX5	3.01e-04	194	38	4	4117_UP
Drug	Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A	CASP2 LHX2 MLXIP TNS1	3.07e-04	195	38	4	4466_DN
Drug	Butylparaben [94-26-8]; Up 200; 20.6uM; MCF7; HT_HG-U133A	CEP104 LHX2 MLXIP ZNF446	3.07e-04	195	38	4	5608_UP
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	CASP2 LHX2 MLXIP SH3BP2	3.07e-04	195	38	4	2283_DN
Drug	Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A	CASP2 MLXIP BTD SH3BP2	3.07e-04	195	38	4	3266_UP
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A	EHHADH BTD EPHA1 AOX1	3.07e-04	195	38	4	2311_DN
Drug	Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A	MLXIP TNS1 SH3BP2 TBX5	3.07e-04	195	38	4	2833_UP
Drug	Phenindione [83-12-5]; Up 200; 18uM; MCF7; HT_HG-U133A	TNS1 ZNF446 SH3BP2 TBX5	3.07e-04	195	38	4	2868_UP
Drug	Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A	CASP2 TMEM62 ZNF446 SH3BP2	3.13e-04	196	38	4	7200_UP
Drug	Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A	CEP104 TNS1 BTD SH3BP2	3.13e-04	196	38	4	5488_UP
Drug	Acacetin [480-44-4]; Up 200; 14uM; PC3; HT_HG-U133A	CASP2 DMXL2 MLXIP SH3BP2	3.13e-04	196	38	4	4324_UP
Drug	Triamterene [396-01-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A	EHHADH BTD SH3BP2 AOX1	3.13e-04	196	38	4	1697_UP
Drug	Etilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A	CASP2 TNS1 SH3BP2 TBX5	3.13e-04	196	38	4	4415_UP
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	CASP2 ZNF446 EPHA1 TBX5	3.13e-04	196	38	4	3971_DN
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; MCF7; HT_HG-U133A	BTD ZNF446 SH3BP2 AOX1	3.13e-04	196	38	4	4775_DN
Drug	Spiramycin [8025-81-8]; Up 200; 4.8uM; PC3; HT_HG-U133A	MLXIP CCDC6 BTD EPHA1	3.13e-04	196	38	4	4319_UP
Drug	Rifampicin [13292-46-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A	CASP2 LHX2 DMXL2 TBX5	3.13e-04	196	38	4	2847_UP
Drug	Chelidonine monohydrate (+) [476-32-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A	CASP2 MED24 LHX2 EPHA1	3.13e-04	196	38	4	6236_DN
Drug	Propylthiouracil [51-52-5]; Up 200; 23.4uM; MCF7; HT_HG-U133A	CASP2 DMXL2 MLXIP ZNF446	3.13e-04	196	38	4	2837_UP
Drug	Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A	MLXIP ZNF446 SH3BP2 TBX5	3.13e-04	196	38	4	2862_UP
Drug	Loracarbef [121961-22-6]; Down 200; 10.8uM; PC3; HT_HG-U133A	TNS1 BTD SH3BP2 EPHA1	3.13e-04	196	38	4	5073_DN
Drug	Timolol maleate salt [26921-17-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A	TMEM62 BTD ZNF446 EPHA1	3.13e-04	196	38	4	6483_DN
Drug	Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A	CASP2 LHX2 SH3BP2 EPHA1	3.13e-04	196	38	4	4739_DN
Drug	Tranexamic acid [1197-18-8]; Down 200; 25.4uM; MCF7; HT_HG-U133A	ABHD14A TMEM62 BTD EPHA1	3.13e-04	196	38	4	6238_DN
Drug	5186223; Down 200; 12uM; MCF7; HT_HG-U133A_EA	CEP104 ABHD14A LHX2 SH3BP2	3.19e-04	197	38	4	885_DN
Drug	Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A	CASP2 SH3BP2 EPHA1 AOX1	3.19e-04	197	38	4	1518_DN
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	ABHD14A MLXIP TNS1 SH3BP2	3.19e-04	197	38	4	3837_DN
Drug	CP-320650-01 [172079-28-6]; Down 200; 1uM; PC3; HT_HG-U133A	MLXIP ZNF446 SH3BP2 TBX5	3.19e-04	197	38	4	3825_DN
Drug	Bethanechol chloride [590-63-6]; Down 200; 20.4uM; HL60; HT_HG-U133A	PEPD CEP104 BTD SH3BP2	3.19e-04	197	38	4	2975_DN
Drug	Pirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	CASP2 MLXIP SH3BP2 ZIC3	3.19e-04	197	38	4	5274_DN
Drug	Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A	CASP2 BTD SH3BP2 ZIC3	3.19e-04	197	38	4	3551_UP
Drug	Isosorbide dinitrate [87-33-2]; Up 200; 17uM; MCF7; HT_HG-U133A	CASP2 TNS1 ZIC3 TBX5	3.19e-04	197	38	4	4742_UP
Drug	copper(II) sulfate pentahydrate; Down 200; 100uM; MCF7; HG-U133A	CEP104 LHX2 TNS1 TBX5	3.19e-04	197	38	4	438_DN
Drug	Triflusal [322-79-2]; Down 200; 16.2uM; HL60; HG-U133A	CASP2 PTPN4 MLXIP SH3BP2	3.19e-04	197	38	4	1717_DN
Drug	CGX 0596987; Up 200; 20uM; MCF7; HT_HG-U133A	CASP2 TNS1 SH3BP2 ALPL	3.19e-04	197	38	4	6412_UP
Drug	Ethionamide [536-33-4]; Up 200; 24uM; MCF7; HT_HG-U133A	CASP2 TNS1 SH3BP2 TBX5	3.19e-04	197	38	4	4418_UP
Drug	Brompheniramine maleate [980-71-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A	DMXL2 SH3BP2 AOX1 TBX5	3.19e-04	197	38	4	4131_UP
Drug	Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A	CEP104 ABHD14A BTD SH3BP2	3.19e-04	197	38	4	4777_DN
Drug	Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; MCF7; HT_HG-U133A	LHX2 MLXIP TNS1 ALPL	3.25e-04	198	38	4	2294_UP
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A	CASP2 LHX2 DMXL2 EPHA1	3.25e-04	198	38	4	4762_DN
Drug	iloprost; Down 200; 1uM; SKMEL5; HG-U133A	MLXIP TNS1 EPHA1 ZNF184	3.25e-04	198	38	4	496_DN
Drug	Cholecalciferol [67-97-0]; Up 200; 10.4uM; PC3; HT_HG-U133A	CASP2 ZNF446 SH3BP2 TBX5	3.25e-04	198	38	4	6656_UP
Drug	PNU-0230031 [267429-39-0]; Down 200; 1uM; MCF7; HT_HG-U133A	LHX2 BTD SH3BP2 TBX5	3.25e-04	198	38	4	3632_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A	TMEM62 SH3BP2 EPHA1 TBX5	3.25e-04	198	38	4	5583_DN
Drug	Antipyrine [60-80-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A	CEP104 MLXIP ZNF446 SH3BP2	3.25e-04	198	38	4	1489_UP
Drug	W-13, hydrochloride; Down 200; 10uM; MCF7; HG-U133A	LHX2 TNS1 BTD TBX5	3.25e-04	198	38	4	440_DN
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	MED24 TMEM62 TNS1 BTD	3.25e-04	198	38	4	7303_DN
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	CASP2 ABHD14A LHX2 BTD	3.25e-04	198	38	4	6935_UP
Drug	Tribenoside [10310-32-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A	CCDC6 TNS1 SH3BP2 EPHA1	3.25e-04	198	38	4	5429_UP
Drug	Chlorpropamide [94-20-2]; Down 200; 14.4uM; MCF7; HT_HG-U133A	CASP2 SH3BP2 EPHA1 AOX1	3.25e-04	198	38	4	5391_DN
Drug	(-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CASP2 CEP104 TMEM62 SH3BP2	3.31e-04	199	38	4	5003_DN
Drug	Isocarboxazid [59-63-2]; Down 200; 17.2uM; HL60; HT_HG-U133A	PTPN4 DMXL2 BTD SH3BP2	3.31e-04	199	38	4	2562_DN
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; HL60; HT_HG-U133A	CASP2 CEP104 DMXL2 BICRAL	3.31e-04	199	38	4	2556_DN
Drug	Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; PC3; HT_HG-U133A	CASP2 LHX2 BTD EPHA1	3.31e-04	199	38	4	7275_UP
Drug	TTNPB; Down 200; 0.1uM; MCF7; HG-U133A	LHX2 MLXIP TNS1 ZNF446	3.31e-04	199	38	4	223_DN
Drug	PHA-00851261E [724719-49-7]; Up 200; 1uM; PC3; HT_HG-U133A	CASP2 TNS1 SH3BP2 ALPL	3.38e-04	200	38	4	3776_UP
Drug	Vitexin [3681-93-4]; Down 200; 9.2uM; MCF7; HT_HG-U133A	DMXL2 BICRAL MLXIP AOX1	3.38e-04	200	38	4	4413_DN
Drug	Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; PC3; HT_HG-U133A	CASP2 TMEM62 ZNF446 SH3BP2	3.38e-04	200	38	4	5842_DN
Drug	ss,ss-carotene	PEPD CCDC6 ALPL PYROXD2	3.44e-04	201	38	4	CID000000573
Drug	isovanillin	LHX2 AOX1	4.08e-04	18	38	2	CID000012127
Drug	Hlnl	PEPD LHX2	4.56e-04	19	38	2	CID000122155
Disease	vitamin B6 measurement	ALPL PYROXD2	6.47e-05	10	36	2	EFO_0004621
Disease	QRS amplitude, QRS complex	ZNF184 TBX5	1.71e-03	50	36	2	EFO_0005054, EFO_0007742
Disease	Hepatomegaly	PEPD A1BG	1.99e-03	54	36	2	C0019209

Protein segments in the cluster

Peptide	Gene	Start	Entry
GHLHTLGGLMPVLHT	TMEM62	256	Q0P6H9
GVHSPLMKAQFITHH	nan	16	Q6ZRP5
IMGQFSHPHILHLEG	EPHA1	676	P21709
VGSMVEHYHTHVLPS	SH3BP2	531	P78314
PGLHVQHMGTSHGIT	CCDC6	396	Q16204
HTLLHQEGMSVGSPH	DMXL2	576	Q8TDJ6
GHPIMHLSGVKHATG	AOX1	581	Q06278
QAHLGAVFMPHGLGH	PEPD	356	P12955
HVRCLLTPGHTAGHM	HAGHL	101	Q6PII5
GGSHHKVSVSPVVHV	HNRNPLL	66	Q8WVV9
LRPSSVGHLVDHMVH	PTPN4	411	P29074
VLMHHGESSQVLHPG	A1BG	211	P04217
LMRGHHQLHGFVPIA	ABHD14A	181	Q9BUJ0
VLHHMVKISGGPHIS	MAGEA3	286	P43357
FGHTVLVGSHIVPHM	FER1L4	1016	A9Z1Z3
EIPFKFHMLHSGLVH	CARM1	371	Q86X55
HLVIGTHFFSPAHVM	EHHADH	426	Q08426
MLFHSLSGPEVHGVI	LHX2	1	P50458
VFSKGPMAHLLHGVH	ALPL	461	P05186
IIHSGHFMVSSPHRE	MLXIP	76	Q9HAP2
MPHKIGFVVVSSSGH	CEP104	1	O60308
HGFMQHVGISVPSQH	BICRAL	186	Q6AI39
VHHPVLGMTGSGIHT	BTD	301	P43251
GVPHVITATLHIIMG	CERKL	311	Q49MI3
VMVHGRNHTPFLGHH	SCNN1D	491	P51172
ILGVCGMHPHHQETL	CASP2	26	P42575
GHRIIPHTYCEHMGI	OR52E8	176	Q6IFG1
FGGHTIPLHIHIIMA	OR52N1	266	Q8NH53
TLSPHQYHSVHGVGM	TBX5	496	Q99593
HHPGCGGTTLAMHVL	SAMD9L	741	Q8IVG5
TIGLTGIHLHTHYVM	PKDREJ	1146	Q9NTG1
VHAEQMHKTGFPTVH	MED24	231	O75448
GSIKEMSHHPPGHTV	HRC	456	P23327
IESGRMTHHHPTGYL	ADPRH	156	P54922
HELVTHVTMEHVGGP	ZIC3	276	O60481
PHTPGSGYVLLHHVM	PYROXD2	256	Q8N2H3
LHHVIMHGIPNFESK	TNS1	186	Q9HBL0
VFVIHHRTHTSGPGV	ZNF446	346	Q9NWS9
GPSTFIRHHMIHTGE	ZNF184	401	Q99676